Daewoong Pharmaceutical's Diabetes Drug Envlo Wins Mexico Approval (Seoul Economic Daily) - May 26, 2026 - Daewoong Pharmaceutical announced in a regulatory filing...that it recently obtained product approval for Envlo Tablets 0.3mg, a treatment for type 2 diabetes, from Mexico's Federal Commission for the Protection against Sanitary Risks (COFEPRIS).
Approval • Type 2 Diabetes Mellitus
|